Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Twitter’s legal woes mount as former PR firm files lawsuit for unpaid invoices

    May 30, 2023

    India’s mastery in space: ISRO’s successful launch of Cartosat-3 satellite

    May 29, 2023

    Global clean energy investment set to reach $1.7 trillion, overtaking oil production

    May 27, 2023
    Facebook Twitter Instagram
    Arab OutlookArab Outlook
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    Arab OutlookArab Outlook
    Home » Hoth Therapeutics expands with Novel Alzheimer’s Treatment
    Health

    Hoth Therapeutics expands with Novel Alzheimer’s Treatment

    February 25, 2021
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email

    Hoth Therapeutics, Inc., a biopharmaceutical company, announced it has filed a provisional patent application with the United States Patent and Trademark Office for the use of one of its current portfolio therapeutics to treat and prevent Alzheimer’s disease.  

    Hoth also secured an exclusive license agreement with respect to the use of this drug for other indications. Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that is associated with the destruction of higher brain structures, such as those involved in memory and cognition. 

    The disease leads to deficits in cognitive function and declines in memory, learning, language, and in the ability to perform intentional and purposeful movements. The disease is predicted to increase at least threefold between 2000 and 2050, rendering AD a world-wide public health problem.

    
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth’s pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma and acne. 

    Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email

    Related Posts

    Resting heart rate: The overlooked metric in cardiac health assessment

    May 25, 2023

    Global healthcare experts gather in Dubai for PMES 2023

    May 23, 2023

    New study highlights potential of Pfizer’s oral weight loss drug as alternative to Ozempic

    May 22, 2023

    Exercise at certain times of the day increases longevity

    February 25, 2023
    Latest News

    Twitter’s legal woes mount as former PR firm files lawsuit for unpaid invoices

    May 30, 2023

    India’s mastery in space: ISRO’s successful launch of Cartosat-3 satellite

    May 29, 2023

    Global clean energy investment set to reach $1.7 trillion, overtaking oil production

    May 27, 2023

    European Investment Bank supports circular economy with €3.4 billion lending

    May 27, 2023

    WHO report urges governments: prioritize food security over tobacco industry

    May 27, 2023

    Successful UAE-India partnership stands as a model of bilateral cooperation

    May 27, 2023

    India soaring to new heights: the impact of nine years of Modi’s leadership

    May 25, 2023

    Tina Turner passes, but her music forever echoes in the heart of rock’n’roll

    May 25, 2023
    © 2021 Arab Outlook | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.